1887

Journal of General Virology header logo

Volume 84, Issue 3

The regulation of hepatitis C virus (HCV) internal ribosome-entry site-mediated translation by HCV replicons and nonstructural proteins Free

Abstract

Hepatitis C virus (HCV), the global leading cause of chronic liver disease, has a positive-sense, ssRNA genome that encodes a large polyprotein. HCV polyprotein translation is initiated by an internal ribosome-entry site (IRES) located at the 5′ end of the viral genome, in a cap-independent manner, but the regulatory mechanism of this process remains poorly understood. In this study, we characterized the effect of HCV nonstructural proteins on HCV IRES-directed translation in both HCV replicon cells and transiently transfected human liver cells expressing HCV nonstructural proteins. Using bicistronic reporter gene constructs carrying either HCV or other viral IRES sequences, we found that the HCV IRES-mediated translation was specifically upregulated in HCV replicon cells. This enhancement of HCV IRES-mediated translation by the replicon cells was inhibited by treatment with either type I interferon or ribavirin, drugs that perturb HCV genome replication, suggesting that the enhancement is probably due to HCV-encoded protein function(s). Reduced phosphorylation levels of both eIF2 and eIF4E were observed in the replicon cells, which is consistent with our previous findings and indicates that the NS5A nonstructural protein may be involved in the regulatory mechanism(s). Indeed, transient expression of NS5A or NS4B in human liver cells stimulated HCV IRES activity. Interestingly, mutation in the ISDR of NS5A perturbed this stimulation of HCV IRES activity. All these results suggest, for the first time, that HCV nonstructural proteins preferentially stimulate the viral cap-independent, IRES-mediated translation.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18658-0
2003-03-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/3/vir840535.html?itemId=/content/journal/jgv/10.1099/vir.0.18658-0&mimeType=html&fmt=ahah

References

  1. Alter M. J. 1997; Epidemiology of hepatitis C. Hepatology 26:62S–65S
     [Google Scholar]
  2. Blight K. J., Kolykhalov A. A., Rice C. M. 2000; Efficient initiation of HCV RNA replication in cell culture. Science 290:1972–1974
     [Google Scholar]
  3. Chung R. T., He W., Saquib A., Contreras A. M., Xavier R. J., Chawla A., Wang T. C., Schmidt E. V. 2001; Hepatitis C virus replication is directly inhibited by IFN- α in a full-length binary expression system. Proc Natl Acad Sci U S A 98:9847–9852
     [Google Scholar]
  4. Collier A. J., Tang S., Elliott R. M. 1998; Translation efficiencies of the 5′ untranslated region from representatives of the six major genotypes of hepatitis C virus using a novel bicistronic reporter assay system. J Gen Virol 79:2359–366
     [Google Scholar]
  5. Creancier L., Mercier P., Prats A. C., Morello D. 2001; c- myc Internal ribosome entry site activity is developmentally controlled and subjected to a strong translational repression in adult transgenic mice. Mol Cell Biol 21:1833–1840
     [Google Scholar]
  6. Frese M., Pietschmann T., Moradpour D., Haller O., Bartenschlager R. 2001; Interferon- α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 82:723–733
     [Google Scholar]
  7. Gale M. Jr., Beard M. R. 2001; Molecular clones of hepatitis C virus: applications to animal models. ILAR J 42:139–151
     [Google Scholar]
  8. Gale M. J., Korth M. J., Tang N. M., Tan S. L., Hopkins D. A., Dever T. E., Polyak S. J., Gretch D. R., Katze M. G. 1997; Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230:217–227
     [Google Scholar]
  9. Gale M., Blakely C. M., Kwieciszewski B. 7 other authors 1998; Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18:5208–5218
     [Google Scholar]
  10. Gale M., Kwieciszewski B., Dossett M., Nakao H., Katze M. G. 1999; Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J Virol 73:6506–6516
     [Google Scholar]
  11. Gale M., Tan S. L., Katze M. G. 2000; Translational control of viral gene expression in eukaryotes. Microbiol Mol Biol Rev 64:239–280
     [Google Scholar]
  12. Gingras A. C., Raught B., Sonenberg N. 1999; eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68:913–963
     [Google Scholar]
  13. Hambidge S. J., Sarnow P. 1992; Translational enhancement of the poliovirus 5′ noncoding region mediated by virus-encoded polypeptide 2A. Proc Natl Acad Sci U S A 89:10272–10276
     [Google Scholar]
  14. He Y., Katze M. G. 2002; To interfere and to anti-interfere: the interplay between hepatitis C virus and interferon. Viral Immunology 15:95–119
     [Google Scholar]
  15. He Y., Tan S. L., Tareen S. U., Vijaysri S., Langland J. O., Jacobs B. L., Katze M. G. 2001; Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A. J Virol 75:5090–5098
     [Google Scholar]
  16. He Y., Nakao H., Tan S. L., Polyak S. J., Neddermann P., Vijaysri S., Jacobs B. L., Katze M. G. 2002; Subversion of host signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and p85 PI3-kinase. J Virol 76:9207–9217
     [Google Scholar]
  17. Hellen C. U., Pestova T. V. 1999; Translation of hepatitis C virus RNA. J Viral Hepat 6:79–87
     [Google Scholar]
  18. Hellen C. U., Sarnow P. 2001; Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev 15:1593–1612
     [Google Scholar]
  19. Honda M., Brown E. A., Lemon S. M. 1996; Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA 2:955–968
     [Google Scholar]
  20. Honda M., Rijnbrand R., Abell G., Kim D., Lemon S. M. 1999; Natural variation in translational activities of the 5′ nontranslated RNAs of hepatitis C virus genotypes 1a and 1b: evidence for a long- range RNA–RNA interaction outside of the internal ribosomal entry site. J Virol 73:4941–4951
     [Google Scholar]
  21. Honda M., Kaneko S., Matsushita E., Kobayashi K., Abell G. A., Lemon S. M. 2000; Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology 118:152–162
     [Google Scholar]
  22. Hoofnagle J. H. 1997; Hepatitis C: the clinical spectrum of disease. Hepatology 26:15S–20S
     [Google Scholar]
  23. Hoofnagle J. H. 1999; Management of hepatitis C: current and future perspectives. J Hepatol 31:264–268
     [Google Scholar]
  24. Jubin R. 2001; Hepatitis C IRES: translating translation into a therapeutic target. Curr Opin Mol Ther 3:278–287
     [Google Scholar]
  25. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R. 1999; Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110–113
     [Google Scholar]
  26. Maag D., Castro C., Hong Z., Cameron C. E. 2001; Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin. J Biol Chem 276:46094–46098
     [Google Scholar]
  27. Macadam A. J., Ferguson G., Fleming T., Stone D. M., Almond J. W., Minor P. D. 1994; Role for poliovirus protease 2A in cap independent translation. EMBO J 13:924–927
     [Google Scholar]
  28. Moradpour D., Blum H. E. 1999; Current and evolving therapies for hepatitis C. Eur J Gastroenterol Hepatol 11:1199–202
     [Google Scholar]
  29. Pietschmann T., Lohmann V., Rutter G., Kurpanek K., Bartenschlager R. 2001; Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J Virol 75:1252–1264
     [Google Scholar]
  30. Poulin F., Gingras A. C., Olsen H., Chevalier S., Sonenberg N. 1998; 4E-BP3, a new member of the eukaryotic initiation factor 4E-binding protein family. J Biol Chem 273:14002–14007
     [Google Scholar]
  31. Reed K. E., Rice C. M. 2000; Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242:55–84
     [Google Scholar]
  32. Reynolds J. E., Kaminski A., Kettinen H. J., Grace K., Clarke B. E., Carroll A. R., Rowlands D. J., Jackson R. J. 1995; Unique features of internal initiation of hepatitis C virus RNA translation. EMBO J 14:6010–6020
     [Google Scholar]
  33. Rijnbrand R. C., Lemon S. M. 2000; Internal ribosome entry site-mediated translation in hepatitis C virus replication. Curr Top Microbiol Immunol 242:85–116
     [Google Scholar]
  34. Rijnbrand R., Bredenbeek P., van der Straaten T., Whetter L., Inchauspe G., Lemon S., Spaan W. 1995; Almost the entire 5′ non-translated region of hepatitis C virus is required for cap-independent translation. FEBS Lett 365:115–119
     [Google Scholar]
  35. Sonenberg N., Gingras A. C. 1998; The mRNA 5′ cap-binding protein eIF4E and control of cell growth. Curr Opin Cell Biol 10:268–275
     [Google Scholar]
  36. Taylor D. R., Shi S. T., Romano P. R., Barber G. N., Lai M. M. 1999; Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285:107–110
     [Google Scholar]
  37. Thompson S. R., Sarnow P. 2000; Regulation of host cell translation by viruses and effects on cell function. Curr Opin Microbiol 3:366–370
     [Google Scholar]
  38. Tomei L., Failla C., Santolini E., De Francesco R., La Monica N. 1993; NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol 67:4017–4026
     [Google Scholar]
  39. Varaklioti A., Vassilaki N., Georgopoulou U., Mavromara P. 2002; Alternate translation occurs within the core coding region of the hepatitis C viral genome. J Biol Chem 277:17713–17721
     [Google Scholar]
  40. Ventoso I., Carrasco L. 1995; A poliovirus 2Apro mutant unable to cleave 3CD shows inefficient viral protein synthesis and transactivation defects. J Virol 69:6280–6288
     [Google Scholar]
  41. Walewski J. L., Keller T. R., Stump D. D., Branch A. D. 2001; Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 7:710–721
     [Google Scholar]
  42. Wang T. H., Rijnbrand R. C., Lemon S. M. 2000; Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. J Virol 74:11347–11358
     [Google Scholar]
  43. Wilson J. E., Pestova T. V., Hellen C. U., Sarnow P. 2000; Initiation of protein synthesis from the A site of the ribosome. Cell 102:511–520
     [Google Scholar]
  44. Xu Z., Choi J., Yen T. S. B., Lu W., Strohecker A., Govindarajan S., Chien D., Selby M. J., Ou J.-H. 2001; Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J 20:3840–3848
     [Google Scholar]
  45. Zhang J., Yamada O., Yoshida H., Iwai T., Araki H. 2002; Autogenous translational inhibition of core protein: implication for switch from translation to RNA replication in hepatitis C virus. Virology 293:141–150
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.18658-0
Loading
The regulation of hepatitis C virus (HCV) internal ribosome-entry site-mediated translation by HCV replicons and nonstructural proteins
J. Gen. Virol. 84, 535 (2003); https://doi.org/10.1099/vir.0.18658-0
/content/journal/jgv/10.1099/vir.0.18658-0
/content/journal/jgv/10.1099/vir.0.18658-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error